OmniVis is a South San Francisco based biotechnology company that specializes in rapid medical diagnostic tests.Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii Co-founded by Dr. Katherine Clayton, a Purdue College of Engineering graduate alumna, and three professors, OmniVis produces cholera test and is working on COVID-19 tests.
Products
Cholera detection OmnniVis's rapid Cholera detection device can identify the presence of Vibrio cholerae in water in less than one hour. The device uses a process of DNA amplification and viscosity measurement.
The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element. In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.
COVID-19 detection In May 2020, OmniVis was working on the early stages of a rapid test for COVID-19 that detects the disease in human saliva. The rapid tests uses a smartphone for processing. The project was supported by the United States Department of Agriculture. From June 2020, OmniVis was also working on a United States National Science Foundation funded initiative to detect COVID-19 from nasal swabs.
References
External links
Official website